Clinical research that three kinds of Glycyrrhizin to chronic B liver sufferer's blood sugar and liver function viruses affect

LEI Yu,LU Hai-ying,XU Xiao-yuan,TIAN Geng-Shan

DOI: https://doi.org/10.3969/j.issn.1008-2395.2006.04.009

2006-01-01

Abstract:[Objective] To investigate the effect of Glycyrrhizin on blood sugar in HBV patients.[Methods] Ninety-five HBV patients were randomly divided into group A、group B and group C,which were treated with intravenous Compound Glycyrrhizin(80ml)、Compound Ammonium Glycyrrhetate(120ml) and Diammonium Glycyrrhizinate(40ml)respectively.The fasting blood sugar、liver functions、HBVM and HBV-DNA were measured,respectively before the administration and after the corresponding treatments for 2 weeks and 4 weeks.[Results] The level of fasting blood sugar before treatment were 5.28±1.75mmol/L、5.32±1.66mmol/L and 5.65±1.82mmol/L respectively.After treatments for 2 weeks,the level of fasting blood sugar in each group initially decreased.After treatments for 4 weeks,the level of fasting blood sugar were 4.51±1.65mmol/L、4.68±1.37mmol/L and 4.98±1.87mmol/L,which were decreased to some extent in contrast to the pre-treatment period.However,there were no significant difference between pre-treatments and post-treatments as well as the decreasing level(P>0.05).[Conclusion] The level of blood sugar was not increased by Glycyrrhizin in the HBV patients,however,decreased by some dose of Glycyrrhizin.